Rigel Pharmaceuticals, Inc.

Q3 2025 13F Holders

Symbol
RIGL
CUSIP
766559702
Type
Equity
Class
COM
Num filings
172
Total reported value, excl. options
$426 M
Manager Report Date Value ($000) Shares Option Type